Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,398.93
+0.8%
+61.82
Arrow-Thin-Down
DJI
49,609.16
+0.0%
+12.19
Arrow-Thin-Down
NASDAQ
26,247.08
+1.7%
+440.88
Arrow-Thin-Down
Bitcoin
$80,664.00
-0.1%
-$89.45
Arrow-Thin-Down
AAPL
$293.41
+2.1%
+$5.97
Arrow-Thin-Down
AMZN
$272.66
+0.5%
+$1.49
Arrow-Thin-Down
GOOG
$396.94
+0.4%
+$1.64
Arrow-Thin-Down
META
$609.53
-1.2%
-$7.28
Arrow-Thin-Down
MSFT
$415.17
-1.3%
-$5.60
Arrow-Thin-Down
NVDA
$215.16
+1.7%
+$3.66
Arrow-Thin-Down
TSLA
$427.99
+3.9%
+$16.20
Most Active StocksDaily Stock GainersDaily Stock Losers
Krystal Biotech logo

Krystal Biotech

(NASDAQ) KRYS

Current Price$305.99
Market Cap$9.01B
Since IPO (2017)+2,773%
5 Year+332%
1 Year+123%
1 Month+16%

Krystal Biotech Financials at a Glance

Market Cap

$9.01B

Revenue (TTM)

$417.30M

Net Income (TTM)

$225.03M

EPS (TTM)

$7.48

P/E Ratio

40.86

Dividend

$0.00

Beta (Volatility)

1.28 (Average)

Price

$305.99

Volume

470,598.829

Open

$297.00

Previous Close

$305.71

Daily Range

$292.00 - $306.10

52-Week Range

$122.80 - $306.10

KRYS News

Doctor holding clipboard stands with virtual DNA double helix in the air near him.

Best Genomics Stocks for 2026 and How to Invest

Lyle DalyApr 18, 2026
Doctor and patient in a hospital room.

3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist

Prosper Junior BakinyApr 16, 2026
Person sitting and working at a desk.

Could This Under-the-Radar Healthcare Stock Set You Up for Life?

Prosper Junior BakinyApr 7, 2026
BuyAlert-Purple.png

Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025

Jonathan PoncianoFeb 22, 2026
allergies

Got $300? 2 Biotech Stocks to Buy and Hold Forever

James HalleyFeb 16, 2026
Foolcom-Featured.png

Krystal (KRYS) Q2 Profit Jumps 143%

Motley Fool Markets TeamAug 4, 2025
Physician shaking patient's hand.

This Stock Has Quadrupled in 5 Years. Can It Do It Again?

Prosper Junior BakinyNov 10, 2023
Doctor with patient talking

Up 48% in 2023, Is This Biotech Stock a Buy?

Prosper Junior BakinyJun 3, 2023
Page 1

KRYS: Motley Fool Moneyball Superscore

83

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Krystal Biotech

Industry

Biotechnology

Sector

Health Care

Employees

295

CEO

Krish S. Krishnan, MBA

Website

www.krystalbio.com

Headquarters

Pittsburgh, PA 15203, US

KRYS Financials

Key Financial Metrics (TTM)

Gross Margin

93%

Operating Margin

43%

Net Income Margin

54%

Return on Equity

20%

Return on Capital

14%

Return on Assets

16%

Earnings Yield

2.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.01B

Shares Outstanding

29.48M

Volume

470.60K

Avg. Volume

295.12K

Financials (TTM)

Gross Profit

$360.36M

Operating Income

$161.29M

EBITDA

$167.85M

Operating Cash Flow

$200.87M

Capital Expenditure

$11.95M

Free Cash Flow

$188.91M

Cash & ST Invst.

$827.79M

Total Debt

$9.34M

Krystal Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$116.36M

+31.9%

Gross Profit

$110.03M

+32.3%

Gross Margin

94.57%

N/A

Market Cap

$9.01B

N/A

Market Cap/Employee

$32.77M

N/A

Employees

275

N/A

Net Income

$55.93M

+56.5%

EBITDA

$55.41M

+46.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$821.61M

+35.3%

Accounts Receivable

$127.02M

+23.0%

Inventory

$42.65M

+42.4%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$1.80M

+32.2%

Return on Assets

16.11%

N/A

Return on Invested Capital

13.87%

N/A

Free Cash Flow

$73.23M

+195.7%

Operating Cash Flow

$80.38M

+159.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARWRArrowhead Pharmaceuticals, Inc.
$72.68-6.76%
PCVXVaxcyte, Inc.
$53.01+2.97%
MTSRMetsera, Inc.
$70.50-0.35%
ACLXArcellx, Inc.
$115.07+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
RXTRackspace Technology
$5.49+0.56%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.62+0.08%
IRENIren
$61.20+0.08%
NOKNokia
$12.82+0.04%

Questions About KRYS

What is the current price of Krystal Biotech?

Krystal Biotech is trading at $305.71 per share.

What is the 52-week range for Krystal Biotech?

Over the past 52 weeks, Krystal Biotech has traded between $122.80 and $306.10.

How much debt does Krystal Biotech have?

As of the most recent reporting period, Krystal Biotech reported total debt of $9.11M.

How much cash does Krystal Biotech have on hand?

Krystal Biotech reported $501.31M in cash and cash equivalents in its most recent financial results.

What is Krystal Biotech’s dividend yield?

Krystal Biotech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services